Nebraska Hematology Oncology P C is a clinical research site located in Lincoln, Nebraska, United States 68506.
Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.
Nebraska Hematology Oncology P C has participated in 13 clinical trials with 4 currently active.
Therapeutic areas: Triple Negative Breast Cancer, Breast Cancer, Carcinoma, Transitional Cell.
Sponsors: G1 Therapeutics, Inc., Astellas Pharma Global Development, Inc., Ariad Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Nebraska · View every site in Lincoln
Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Nebraska Hematology Oncology P C has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nebraska Hematology Oncology P C has 13 clinical trials on record, with 4 currently active. Their work covers Triple Negative Breast Cancer, Breast Cancer, Carcinoma, Transitional Cell.
Nebraska Hematology Oncology P C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.